Damon Announces Strategic Transaction and Board UpdateNovember 28, 2025 1:05 PM EST | Source: Damon Inc.Follows recent announcement of Damon's $30 million Reg A+ offering to advance its personal mobility products and AI-enabled connected vehicle strategy at https://invest.damon.com Vancouver, British Columbia--(Newsfile Corp. - November 28, 2025) - Damon Inc. (OTCID: DMNIF) ("Damon" or the "Company"), a designer and developer of electric motorcycles and other personal mobility products that se ...

One of the biggest losers in the market this week has been PagerDuty, Inc. ( PD ). The digital operations management platform has been one of the more disappointing stocks in the market so farI am a market enthusiast and part-time trader. I started writing for Seeking Alpha in 2011, and it has been a tremendous opportunity and learning experience. I have been interested in the markets since elementary school, and hope to pursue a career in the investment management industry. I have been active in the market ...

One of the biggest losers in the market this week has been PagerDuty, Inc. ( PD ). The digital operations management platform has been one of the more disappointing stocks in the market so farI am a market enthusiast and part-time trader. I started writing for Seeking Alpha in 2011, and it has been a tremendous opportunity and learning experience. I have been interested in the markets since elementary school, and hope to pursue a career in the investment management industry. I have been active in the market ...

Our timing in downgrading BNP Paribas ( OTCQX:BNPQF )( OTCQX:BNPQY ) proved fortunate (Fig. 1). Just a few days later, the bank's shares came under pressure amid news of the Sudan case and rising concerns over legal claims.Buy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they might be, and must ...

Core Insights - Vera Therapeutics is a biopharmaceutical company focused on developing treatments for serious diseases, with a current stock price of $33.33 and a price target set by H.C. Wainwright at $90, indicating a potential increase of about 172% [1][5] - The stock recently surged by 13%, influenced by a positive research note from Cantor Fitzgerald's analyst, who reiterated a buy recommendation and set a price target of $100, over three times the current share price [2][5] - The market for IgA Nephropathy treatments is identified as a multi-billion-dollar opportunity, which could significantly boost Vera's revenue if successful [3][5] Stock Performance - VERA's stock has shown volatility, trading between $28.81 and $34.07 recently, with a one-year high of $51.27 and a low of $18.53 [4] - The company's market capitalization is approximately $2.13 billion, indicating its standing in the biopharmaceutical industry [4] - The trading volume of 3,189,748 shares reflects active investor interest in VERA's stock [4]

PresentationPhil UrbanCEO & Executive Director Good morning, ladies and gentlemen, and welcome to the prelims presentation for Mitchells & Butlers for our financial year '24-'25. I'm pleased to be able to report another successful year where we outperformed the market once again in all categories. We delivered 4.3% like-for-like sales growth and 5.8% operating profit growth despite the impact of employees National Insurance, which hit the second half by an unexpected GBP 11 million. With the lowest team tur ...

For in-depth and deep dive research on the casino and gmaing sector, subscribe to The House Edge . New: Free excerpts from our book in progress "The Smartest ever Guide to Gaming Stocks" - free to existing members and new subscribers.Howard Jay Klein has 30 years of experience as an executive and consultant in major casino operations. His background includes: Ballys, Trump Taj Mahal, Mohegan Sun, and Caesars Palace in Las Vegas. He is a value investor first, using management quality to inform his investment ...

London Stock Exchange Group plc - Unsponsored ADR (LSEGY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...

Emcor Group (EME) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Individu ...